Oxford Biomedica Solutions
Alejo Zacarias is a skilled research professional with a solid background in microbiology and laboratory techniques. Currently serving as a Research Associate II at Oxford Biomedica since March 2022, prior experience includes a Research Associate I position at Homology Medicines, Inc., and a Research Assistant role at the University of Massachusetts Amherst, where research focused on the suppression of a gain-of-function transcription factor in multi-drug resistant fungi. Alejo has utilized various laboratory techniques such as endophyte isolation, metabolite isolation, and gas chromatography–mass spectrometry. Educational qualifications include a Bachelor of Arts in Microbiology from Hampshire College and an Associate of Science in Computer Arts from Greenfield Community College.
This person is not in the org chart
This person is not in any offices
Oxford Biomedica Solutions
Oxford Biomedica Solutions, LLC is the high-performing, full scope Adeno-Associated Virus (AAV) vector Manufacturing and Innovation joint venture of Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica” or “the Group”), and Homology Medicines, Inc. (Nasdaq: FIXX) (“Homology”). We offer global pharmaceutical and biotechnology clients innovative manufacturing expertise in AAV and lentiviral-based cell and gene therapies. Oxford Biomedica Solutions LLC provides access to Homology’s innovative and proven end-to-end AAV manufacturing capabilities, and customers also benefit from technical synergies brought in by the Group’s know-how in lentiviral vector manufacturing. This collaborative and complementary vector-based approach has the potential to accelerate our collective mission to improve patients’ lives worldwide.